Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters

Background: The second-line drugs recommended to treat drug-resistant TB are toxic, expensive and difficult to procure. Given increasing resistance, the need for additional anti-TB drugs has become more urgent. But new drugs take time to develop and are expensive. Some commercially available drugs h...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Antimicrob Chemother
Autors principals: Cavanaugh, Joseph S., Jou, Ruwen, Wu, Mei-Hua, Dalton, Tracy, Kurbatova, Ekaterina, Ershova, Julia, Cegielski, J. Peter
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2017
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5890777/
https://ncbi.nlm.nih.gov/pubmed/28333192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkx022
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars